Positive Life NSW Human papillomavirus (HPV) Working Group

The HPV Working Group was established in 2019 to implement key recommendations outlined in the joint survey report: ‘A Community Perspective: on human papillomavirus (HPV)-related cancer among women and, trans and gender diverse people’ (p.30, A Community Perspective 2019):

Raise awareness of HPV-related cancer risk and symptoms (cervical, vaginal, vulvar, and anal) among women and, trans and gender diverse people living with HIV, and immunocompromised women and, trans and gender diverse people;
Increase screening for anogenital HPV-related cancers and particularly anal cancer among women and, trans and gender diverse people living with HIV, and immunocompromised women and, trans and gender diverse people;
Increase vaccination rates among HIV-positive and immunocompromised women and, trans and gender diverse people;
Increase awareness of the new National Cervical Screening Guidelines;
Increase clinician awareness of the need for entire lower anogenital tract examinations among women and, trans and gender diverse people living with HIV, and immunocompromised women and, trans and gender diverse people;
Increase clinician-initiated discussion of HPV-related cancers; among women and, trans and gender diverse people living with HIV, and immunocompromised women and, trans and gender diverse people; and
Increase awareness of HPV-related cancers in the general public and sexual health for women (cis and trans), trans men and gender diverse people.

The group meets quarterly and is made up of health professionals who work with women, other allied health professionals, researchers, stakeholders, and women and trans and gender diverse people with a cervix/vulva/vagina including those living with HIV, and chaired by Positive Life NSW.